Terms ending in 2038
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,150,251 | Bi-Functional Arginine-Glycine-Aspartic Acid (RGD) Peptides and Methods to Promote Angiogenesis In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 10,925,858 | S-Nitrosoglutathione (GSNO) and Gsno Reductase Inhibitors for Use in Therapy In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 10,329,269 | Indene Derivatives and Uses Thereof In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 11,731,952 | Indene Derivatives and Uses Thereof In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,234,285 | Antibodies That Bind INTERLEUKIN-2 and Uses Thereof In force · High confidence | Xoma (US) LLC | In force | High confidence | |
| US 11,000,385 | Expandable Device In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 11,963,980 | Activated CD26-HIGH Immune Cells and CD26-Negative Immune Cells and Uses Thereof In force · High confidence | Musc Foundation for Research Development | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Musc Foundation for Research Development.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.